Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
Brian Berman
Clinical Cosmetic and Investigational Dermatology (2012), pp. 111-111
Open Access | Times Cited: 56

Showing 26-50 of 56 citing articles:

Tolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis.
Lawrence L. Anderson, Michael Jarratt, George Schmieder, et al.
PubMed (2014) Vol. 7, Iss. 12, pp. 19-29
Closed Access | Times Cited: 17
Pepluenone, a new pepluane-type diterpenoid with inhibitory activity on the release of NO from the whole plant of Euphorbia peplus L.
Jianyi Huang, Ying Yang, Hong Liang, et al.
Tetrahedron Letters (2023) Vol. 123, pp. 154550-154550
Closed Access | Times Cited: 5
Phytochemical analysis and evaluation of antioxidant and anti-acetylcholinesterase activities of Euphorbia dendroides L. (Euphorbiaceae) latex
Antonella Smeriglio, Salvatore Ragusa, M.T. Monforte, et al.
Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology (2018) Vol. 153, Iss. 4, pp. 498-505
Closed Access | Times Cited: 16
Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis
Brian Berman
Expert Opinion on Drug Safety (2015) Vol. 14, Iss. 12, pp. 1969-1978
Closed Access | Times Cited: 14
Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial
Andrés M. Erlendsson, Katrine Karmisholt, Christina S. Haak, et al.
Journal of the American Academy of Dermatology (2016) Vol. 74, Iss. 4, pp. 709-715
Closed Access | Times Cited: 13
Macrocyclic diterpenoids from the seeds of Euphorbia peplus with potential activity in inducing lysosomal biogenesis
Yanni Chen, Xiao Ding, Qing-Yun Lu, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104464-104464
Closed Access | Times Cited: 13
Ingenol mebutate: a novel treatment for actinic keratosis
N.J. Collier, Faisal R. Ali, John T. Lear
Clinical Practice (2014) Vol. 11, Iss. 3, pp. 295-306
Open Access | Times Cited: 13
Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases
Juan Antonio Moreno Romero, A. Campoy, Napoleón Paredes Pérez, et al.
British Journal of Dermatology (2015) Vol. 173, Iss. 6, pp. 1514-1517
Closed Access | Times Cited: 13
Diterpenoids with an unprecedented ring system from Euphorbia peplus and their activities in the lysosomal-autophagy pathway
Yanni Chen, Xiao Ding, Dongmei Li, et al.
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 7, pp. 1541-1545
Closed Access | Times Cited: 11
Macrocyclic Diterpenoids from Euphorbia peplus Possessing Activity Towards Autophagic Flux
Lu Chen, L. Liu, Yi Li, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 299-299
Open Access | Times Cited: 1
Semi-Synthetic Ingenol Derivative from Euphorbia tirucalli Inhibits Protein Kinase C Isotypes and Promotes Autophagy and S-Phase Arrest on Glioma Cell Lines
Viviane Aline Oliveira Silva, Marcela N. Rosa, Aline Tansini, et al.
Molecules (2019) Vol. 24, Iss. 23, pp. 4265-4265
Open Access | Times Cited: 12
The Role of Ingenane Diterpenes in Cancer Therapy: From Bioactive Secondary Compounds to Small Molecules
Ana Laura Vieira Alves, Luciane Sussuchi da Silva, Camila A. Faleiros, et al.
Natural Product Communications (2022) Vol. 17, Iss. 7
Closed Access | Times Cited: 7
Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis
Eggert Stockfleth, Mike Bastian
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 14, Iss. 9, pp. 911-918
Closed Access | Times Cited: 11
Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas
A Bucko, Michael Jarratt, Dowling B. Stough, et al.
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 1, pp. 74-79
Closed Access | Times Cited: 10
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments
Tamara Gracia‐Cazaña, Salvador González, Yolanda Gilaberte
Actas Dermo-Sifiliográficas (2016) Vol. 107, Iss. 9, pp. 730-739
Open Access | Times Cited: 9
Jatrophane Diterpenoids from the Seeds of Euphorbia peplus with Potential Bioactivities in Lysosomal-Autophagy Pathway
Yanni Chen, Xiao Ding, Dongmei Li, et al.
Natural Products and Bioprospecting (2021) Vol. 11, Iss. 3, pp. 357-364
Open Access | Times Cited: 9
Ingenol mebutate for the treatment of actinic keratosis: effectiveness and safety in 246 patients treated in real-life clinical practice
Rosa Ortega del Olmo, Rafael Salido‐Vallejo
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 4, pp. 393-399
Open Access | Times Cited: 7
Macrocyclic Diterpenoid Constituents of Euphorbia deflexa, an Endemic Spurge from Greece
Maria-Eleni Grafakou, Christina Barda, Joerg Heilmann, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 11, pp. 2893-2903
Closed Access | Times Cited: 6
Repeated treatments with ingenol mebutate for prophylaxis of UV-induced squamous cell carcinoma in hairless mice
Andrés M. Erlendsson, Daniel Thaysen‐Petersen, Christiane Bay, et al.
Journal of Photochemistry and Photobiology B Biology (2016) Vol. 163, pp. 144-149
Closed Access | Times Cited: 5
PDT and emerging therapies for Actinic Keratosis—A resource letter
José Dirceu Vollet Filho, Cintia Teles de Andrade, Hilde Harb Buzzá, et al.
Photodiagnosis and Photodynamic Therapy (2016) Vol. 17, pp. 205-207
Closed Access | Times Cited: 5
Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos
Tamara Gracia‐Cazaña, Salvador González, Yolanda Gilaberte
Actas Dermo-Sifiliográficas (2016) Vol. 107, Iss. 9, pp. 730-739
Closed Access | Times Cited: 5
Respuesta a ingenol mebutato en los pacientes con queratosis actínicas en la práctica clínica
Ana Batalla, Ángeles Flórez, Carlos Féal, et al.
Actas Dermo-Sifiliográficas (2015) Vol. 106, Iss. 10, pp. e55-e61
Closed Access | Times Cited: 5
Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses
Ana Batalla, Ángeles Flórez, Carlos Féal, et al.
Actas Dermo-Sifiliográficas (2015) Vol. 106, Iss. 10, pp. e55-e61
Open Access | Times Cited: 4
Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives
Luiz Gameiro, Luis Fernando Requejo Tovo, José Antônio Sanches, et al.
Anais Brasileiros de Dermatologia (2019) Vol. 94, Iss. 3, pp. 313-319
Open Access | Times Cited: 3
Ingenol mebutate as topical treatment for actinic keratosis based on a prospective, non-interventional, multicentre study of real-life clinical practice in Germany: efficacy and quality of life
Thomas L. Diepgen, Christoph Eicke, Mike Bastian
European Journal of Dermatology (2019) Vol. 29, Iss. 4, pp. 401-408
Closed Access | Times Cited: 3

Scroll to top